These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11222463)

  • 61. Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks.
    Davis JC; van der Heijde DM; Braun J; Dougados M; Cush J; Clegg D; Inman RD; Kivitz A; Zhou L; Solinger A; Tsuji W
    Ann Rheum Dis; 2005 Nov; 64(11):1557-62. PubMed ID: 15843448
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alopecia areata during etanercept therapy.
    Pan Y; Rao NA
    Ocul Immunol Inflamm; 2009; 17(2):127-9. PubMed ID: 19412875
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
    van Herwaarden N; den Broeder AA; Jacobs W; van der Maas A; Bijlsma JW; van Vollenhoven RF; van den Bemt BJ
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010455. PubMed ID: 25264908
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.
    Bansback NJ; Ara R; Barkham N; Brennan A; Fraser AD; Conway P; Reynolds A; Emery P
    Rheumatology (Oxford); 2006 Aug; 45(8):1029-38. PubMed ID: 16782734
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.
    Davis JC; Van Der Heijde D; Braun J; Dougados M; Cush J; Clegg DO; Kivitz A; Fleischmann R; Inman R; Tsuji W;
    Arthritis Rheum; 2003 Nov; 48(11):3230-6. PubMed ID: 14613288
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Psoriatic arthritis: the role of TNF inhibition and the effect of its inhibition with etanercept.
    Mease P
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S116-21. PubMed ID: 12463460
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome.
    Lo J; Bernstein LE; Canavan B; Torriani M; Jackson MB; Ahima RS; Grinspoon SK
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E102-9. PubMed ID: 17374698
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and safety of etanercept in children and adolescents aged > or = 8 years with severe plaque psoriasis.
    Landells I; Paller AS; Pariser D; Kricorian G; Foehl J; Molta C; Freundlich B
    Eur J Dermatol; 2010; 20(3):323-8. PubMed ID: 20185386
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.
    Hoffman GS; Merkel PA; Brasington RD; Lenschow DJ; Liang P
    Arthritis Rheum; 2004 Jul; 50(7):2296-304. PubMed ID: 15248230
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Etanercept compared to intraarticular corticosteroid injection in rheumatoid arthritis: double-blind, randomized pilot study.
    Roux CH; Breuil V; Valerio L; Amoretti N; Brocq O; Albert C; Grisot C; Allam Y; Chevalier P; Pradier C; Euller-Ziegler L
    J Rheumatol; 2011 Jun; 38(6):1009-11. PubMed ID: 21406499
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial.
    Kreiner F; Galbo H
    Arthritis Res Ther; 2010; 12(5):R176. PubMed ID: 20854662
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Etanercept (Enbrel): update on therapeutic use.
    Spencer-Green G
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i46-9. PubMed ID: 11053088
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Etanercept. Soluble tumour necrosis factor receptor, TNF receptor fusion protein, TNFR-Fc, TNR 001, Enbrel.
    Drugs R D; 1999 Jan; 1(1):75-7. PubMed ID: 10565993
    [No Abstract]   [Full Text] [Related]  

  • 74. Comparative pharmacokinetics of HD203, a biosimilar of etanercept, with marketed etanercept (Enbrel®): a double-blind, single-dose, crossover study in healthy volunteers.
    Yi S; Kim SE; Park MK; Yoon SH; Cho JY; Lim KS; Shin SG; Jang IJ; Yu KS
    BioDrugs; 2012 Jun; 26(3):177-84. PubMed ID: 22515513
    [TBL] [Abstract][Full Text] [Related]  

  • 75. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept.
    Caldarola G; De Simone C; Carbone A; Tulli A; Amerio P; Feliciani C
    Int J Immunopathol Pharmacol; 2009; 22(4):961-6. PubMed ID: 20074459
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluating the tolerability and efficacy of etanercept compared to triamcinolone acetonide for the intralesional treatment of keloids.
    Berman B; Patel JK; Perez OA; Viera MH; Amini S; Block S; Zell D; Tadicherla S; Villa A; Ramirez C; De Araujo T
    J Drugs Dermatol; 2008 Aug; 7(8):757-61. PubMed ID: 18720692
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [A multicenter, double-blind, placebo-controlled, randomized, phase III clinical study of etanercept in treatment of ankylosing spondylitis].
    Huang F; Zhang J; Huang JL; Wu DH; Li ZG; Chen SL; Pan YF; Ma L; Chen S; Lü LJ; Yang ZM
    Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):741-5. PubMed ID: 21092442
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Etanercept at different dosages in the treatment of generalized pustular psoriasis: a case series.
    Esposito M; Mazzotta A; Casciello C; Chimenti S
    Dermatology; 2008; 216(4):355-60. PubMed ID: 18285687
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment.
    Tsimberidou AM; Waddelow T; Kantarjian HM; Albitar M; Giles FJ
    Leuk Res; 2003 May; 27(5):375-80. PubMed ID: 12620287
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients.
    Nemunaitis J; Senzer N; Sarmiento S; Zhang YA; Arzaga R; Sands B; Maples P; Tong AW
    Cancer Gene Ther; 2007 Nov; 14(11):885-93. PubMed ID: 17704755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.